688067.SH
爱威科技
SSE · Healthcare · Medical - Instruments & Supplies · CN
CNY 22.55
−1.44%Year over year
Reported trailing growth
- Revenue
- +4.6%
- EBITDA
- —
- EBIT
- +27.8%
- EPS
- +26.4%
- Free cash flow
- +26.8%
- Operating cash flow
- +30.8%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +3.7%
- EBITDA
- +14.4%
- EBIT
- +17.5%
- Net income
- +17.1%
- EPS
- +18.3%
- Free cash flow
- +65.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026